Page last updated: 2024-10-29

imipramine and Dermal Sinus

imipramine has been researched along with Dermal Sinus in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Research Excerpts

ExcerptRelevanceReference
"We examined whether the existence of spina bifida occulta or ultrasonographic bladder abnormalities was related to the outcome of treatment for primary nocturnal enuresis in children."1.34Location of spina bifida occulta and ultrasonographic bladder abnormalities predict the outcome of treatment for primary nocturnal enuresis in children. ( Miyazato, M; Nishijima, S; Ogawa, Y; Owan, T; Sugaya, K, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyazato, M1
Sugaya, K1
Nishijima, S1
Owan, T1
Ogawa, Y1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Relationship Between Nocturnal Enuresis And Spina Bifida Occulta: A Prospective Controlled Trial[NCT03543995]330 participants (Actual)Observational [Patient Registry]2017-01-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for imipramine and Dermal Sinus

ArticleYear
Location of spina bifida occulta and ultrasonographic bladder abnormalities predict the outcome of treatment for primary nocturnal enuresis in children.
    International journal of urology : official journal of the Japanese Urological Association, 2007, Volume: 14, Issue:1

    Topics: Adolescent; Child; Child, Preschool; Female; Humans; Imipramine; Male; Nocturnal Enuresis; Risk Fact

2007